VEROVACCiNES GmbH

📍 Halle, Germany🗓 Founded 2017👥 10 employees💰 Last funded May 2018
Pharmaceutical Manufacturing🌐 verovaccines.com
Website LinkedIn
VEROVACCiNES develops and markets a novel class of innovative, proprietary subunit marker vaccines for animal health. The technology provides a validated solution to the industry's need for - cost effective vaccines - reduce immunization effort - reduced use of antibiotics A recent development allows to combine several antigens (immunity generating substances) in an single vaccine without increasing production costs. This allows e.g. to target different pathogens with a single vaccine or to generate broad band vaccines targeting immunity evading variants of the same pathogen. The company has a pipeline of 5 vaccine programs at various developmental stages. Four of these programs have already been validated (proof of concept). Several candidates have blockbuster potential. We are developing vaccine solutions for poultry, swine and ruminants. VEROVACCiNES is engaged in collaborations with market leaders as well as with academic institutions.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in VEROVACCiNES GmbH?
VEROVACCiNES GmbH has 1 investors on record on gritt.io, including 1 early-stage backers.
When did VEROVACCiNES GmbH last raise funding?
The most recent investment in VEROVACCiNES GmbH recorded on gritt.io was in May 2018.
When was VEROVACCiNES GmbH founded?
VEROVACCiNES GmbH was founded in 2017.
What industry is VEROVACCiNES GmbH in?
VEROVACCiNES GmbH operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is VEROVACCiNES GmbH based?
VEROVACCiNES GmbH is headquartered in Halle, Germany.